Last reviewed · How we verify

NCT05119491: Ultrasound

Relation Between Pulmonary Function Tests and Ultrasonographic Chest Joints

Completed Last updated 28 January 2025
What this trial tests

trial testing uitrasonography and spirometry in Restrictive Lung Disease in 44 participants. Completed in 21 March 2021.

Timeline
1 January 2019
Primary endpoint
30 December 2020
21 March 2021

Quick facts

Lead sponsorZagazig University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment44
Start date1 January 2019
Primary completion30 December 2020
Estimated completion21 March 2021
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Zagazig University

Who can join

Adults 18 to 75, any sex, with Restrictive Lung Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Ultrasonography can detect different changes in anterior chest wall (ACW) joints in patients with Rheumatoid arthritis (RA) even before being clinically manifested. Airways ,pleura, lung parenchyma and vascular compartment all may be attacked by RA. This study was aiming at detecting the relation between ultrasonographic changes of asymptomatic ACW joints and pulmonary function tests (PFTs) in patients with RA.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Restrictive Lung Disease

Currently open trials in the same condition.

Other Zagazig University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05119491.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing